Catecholaminergic polymorphic ventricular tachycardia electrocardiogram: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 11: Line 11:


==Electrocardiogram==
==Electrocardiogram==
 
* '''Resting [[ECG]]''':
There are no ECG findings associated with [disease name].
**[[CPVT]] patients usually have a normal resting [[ECG]], and the [[QT interval]] is usually not prolonged.<ref name="LeenhardtLucet1995">{{cite journal|last1=Leenhardt|first1=Antoine|last2=Lucet|first2=Vincent|last3=Denjoy|first3=Isabelle|last4=Grau|first4=Francis|last5=Ngoc|first5=Dien Do|last6=Coumel|first6=Philippe|title=Catecholaminergic Polymorphic Ventricular Tachycardia in Children|journal=Circulation|volume=91|issue=5|year=1995|pages=1512–1519|issn=0009-7322|doi=10.1161/01.CIR.91.5.1512}}</ref><ref name="HayashiDenjoy2009">{{cite journal|last1=Hayashi|first1=Meiso|last2=Denjoy|first2=Isabelle|last3=Extramiana|first3=Fabrice|last4=Maltret|first4=Alice|last5=Buisson|first5=Nathalie Roux|last6=Lupoglazoff|first6=Jean-Marc|last7=Klug|first7=Didier|last8=Hayashi|first8=Miyuki|last9=Takatsuki|first9=Seiji|last10=Villain|first10=Elisabeth|last11=Kamblock|first11=Joël|last12=Messali|first12=Anne|last13=Guicheney|first13=Pascale|last14=Lunardi|first14=Joël|last15=Leenhardt|first15=Antoine|title=Incidence and Risk Factors of Arrhythmic Events in Catecholaminergic Polymorphic Ventricular Tachycardia|journal=Circulation|volume=119|issue=18|year=2009|pages=2426–2434|issn=0009-7322|doi=10.1161/CIRCULATIONAHA.108.829267}}</ref><ref name="Sumitomo2003">{{cite journal|last1=Sumitomo|first1=N|title=Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death|journal=Heart|volume=89|issue=1|year=2003|pages=66–70|issn=00070769|doi=10.1136/heart.89.1.66}}</ref>
 
** However, [[sinus bradycardia]] has been reported in approximately 20% of patients, as another consequence of the [[diastolic]] [[calcium]] leakage facilitated by either [[Ryanodine receptor 2|RyR2]] or [[Calsequestrin|CASQ2]] [[mutations]].<ref name="Postma2005">{{cite journal|last1=Postma|first1=A V|title=Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients|journal=Journal of Medical Genetics|volume=42|issue=11|year=2005|pages=863–870|issn=1468-6244|doi=10.1136/jmg.2004.028993}}</ref><ref name="NecoTorrente2012">{{cite journal|last1=Neco|first1=Patricia|last2=Torrente|first2=Angelo G.|last3=Mesirca|first3=Pietro|last4=Zorio|first4=Esther|last5=Liu|first5=Nian|last6=Priori|first6=Silvia G.|last7=Napolitano|first7=Carlo|last8=Richard|first8=Sylvain|last9=Benitah|first9=Jean-Pierre|last10=Mangoni|first10=Matteo E.|last11=Gómez|first11=Ana María|title=
OR
            Paradoxical Effect of Increased Diastolic Ca
 
            2+
An ECG may be helpful in the diagnosis of [disease name]. Findings on an ECG suggestive of/diagnostic of [disease name] include
            Release and Decreased Sinoatrial Node Activity in a Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia
*[Finding 1]
          |journal=Circulation|volume=126|issue=4|year=2012|pages=392–401|issn=0009-7322|doi=10.1161/CIRCULATIONAHA.111.075382}}</ref>
*[Finding 2]
** In addition, prominent [[U wave|U-waves]] are observed in a subset of patients, which may also be related to altered [[intracellular]] [[calcium]] handling. However, its clinical significance is unknown.<ref name="AizawaKomura2006">{{cite journal|last1=Aizawa|first1=Yoshiyasu|last2=Komura|first2=Satoru|last3=Okada|first3=Shinsuke|last4=Chinushi|first4=Masaomi|last5=Aizawa|first5=Yoshifusa|last6=Morita|first6=Hiroshi|last7=Ohe|first7=Tohru|title=Distinct U Wave Changes in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)|journal=International Heart Journal|volume=47|issue=3|year=2006|pages=381–389|issn=1349-2365|doi=10.1536/ihj.47.381}}</ref>
*[Finding 3]
**[[Supraventricular arrhythmias]], including isolated [[ectopic atrial rhythm|atrial ectopic beats]], non-sustained [[supraventricular tachycardia]] and bursts of [[atrial fibrillation]], are present in 16-26% of [[CPVT]] patients, maybe related to co-existing [[sinus node dysfunction]].<ref name="LeenhardtLucet1995">{{cite journal|last1=Leenhardt|first1=Antoine|last2=Lucet|first2=Vincent|last3=Denjoy|first3=Isabelle|last4=Grau|first4=Francis|last5=Ngoc|first5=Dien Do|last6=Coumel|first6=Philippe|title=Catecholaminergic Polymorphic Ventricular Tachycardia in Children|journal=Circulation|volume=91|issue=5|year=1995|pages=1512–1519|issn=0009-7322|doi=10.1161/01.CIR.91.5.1512}}</ref><ref name="SumitomoSakurada2007">{{cite journal|last1=Sumitomo|first1=Naokata|last2=Sakurada|first2=Harumizu|last3=Taniguchi|first3=Kazuo|last4=Matsumura|first4=Masaharu|last5=Abe|first5=Osamu|last6=Miyashita|first6=Michio|last7=Kanamaru|first7=Hiroshi|last8=Karasawa|first8=Kensuke|last9=Ayusawa|first9=Mamoru|last10=Fukamizu|first10=Seiji|last11=Nagaoka|first11=Iori|last12=Horie|first12=Minoru|last13=Harada|first13=Kensuke|last14=Hiraoka|first14=Masayasu|title=Association of Atrial Arrhythmia and Sinus Node Dysfunction in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia|journal=Circulation Journal|volume=71|issue=10|year=2007|pages=1606–1609|issn=1346-9843|doi=10.1253/circj.71.1606}}</ref><ref name="LawrenzKrogmann2013">{{cite journal|last1=Lawrenz|first1=Wolfgang|last2=Krogmann|first2=Otto N.|last3=Wieczorek|first3=Marcus|title=Complex atrial arrhythmias as first manifestation of catecholaminergic polymorphic ventricular tachycardia: an unusual course in a patient with a new mutation in ryanodine receptor type 2 gene|journal=Cardiology in the Young|volume=24|issue=4|year=2013|pages=741–744|issn=1047-9511|doi=10.1017/S1047951113001091}}</ref><ref name="van der WerfNederend2012">{{cite journal|last1=van der Werf|first1=Christian|last2=Nederend|first2=Ineke|last3=Hofman|first3=Nynke|last4=van Geloven|first4=Nan|last5=Ebink|first5=Corné|last6=Frohn-Mulder|first6=Ingrid M.E.|last7=Alings|first7=A. Marco W.|last8=Bosker|first8=Hans A.|last9=Bracke|first9=Frank A.|last10=van den Heuvel|first10=Freek|last11=Waalewijn|first11=Reinier A.|last12=Bikker|first12=Hennie|last13=van Tintelen|first13=J. Peter|last14=Bhuiyan|first14=Zahurul A.|last15=van den Berg|first15=Maarten P.|last16=Wilde|first16=Arthur A.M.|title=Familial Evaluation in Catecholaminergic Polymorphic Ventricular Tachycardia|journal=Circulation: Arrhythmia and Electrophysiology|volume=5|issue=4|year=2012|pages=748–756|issn=1941-3149|doi=10.1161/CIRCEP.112.970517}}</ref><ref name="SyGollob2011">{{cite journal|last1=Sy|first1=Raymond W.|last2=Gollob|first2=Michael H.|last3=Klein|first3=George J.|last4=Yee|first4=Raymond|last5=Skanes|first5=Allan C.|last6=Gula|first6=Lorne J.|last7=Leong-Sit|first7=Peter|last8=Gow|first8=Robert M.|last9=Green|first9=Martin S.|last10=Birnie|first10=David H.|last11=Krahn|first11=Andrew D.|title=Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia|journal=Heart Rhythm|volume=8|issue=6|year=2011|pages=864–871|issn=15475271|doi=10.1016/j.hrthm.2011.01.048}}</ref><ref name="SumitomoNakamura2010">{{cite journal|last1=Sumitomo|first1=Naokata|last2=Nakamura|first2=Takahiro|last3=Fukuhara|first3=Junji|last4=Nakai|first4=Toshiko|last5=Watanabe|first5=Ichiro|last6=Mugishima|first6=Hideo|last7=Hiraoka|first7=Masayasu|title=Clinical effectiveness of pulmonary vein isolation for arrhythmic events in a patient with catecholaminergic polymorphic ventricular tachycardia|journal=Heart and Vessels|volume=25|issue=5|year=2010|pages=448–452|issn=0910-8327|doi=10.1007/s00380-009-1214-6}}</ref><ref name="Faggionivan der Werf2014">{{cite journal|last1=Faggioni|first1=Michela|last2=van der Werf|first2=Christian|last3=Knollmann|first3=Bjorn C.|title=Sinus node dysfunction in catecholaminergic polymorphic ventricular tachycardia: Risk factor and potential therapeutic target?|journal=Trends in Cardiovascular Medicine|volume=24|issue=7|year=2014|pages=273–278|issn=10501738|doi=10.1016/j.tcm.2014.07.001}}</ref>


==References==
==References==

Revision as of 13:00, 23 July 2020

Catecholaminergic polymorphic ventricular tachycardia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Catecholaminergic polymorphic ventricular tachycardia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Exercise Stress Testing

Genetic Testing

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Implantable Cardioverter-Defibrillator

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Catecholaminergic polymorphic ventricular tachycardia electrocardiogram On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Catecholaminergic polymorphic ventricular tachycardia electrocardiogram

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Catecholaminergic polymorphic ventricular tachycardia electrocardiogram

CDC on Catecholaminergic polymorphic ventricular tachycardia electrocardiogram

Catecholaminergic polymorphic ventricular tachycardia electrocardiogram in the news

Blogs on Catecholaminergic polymorphic ventricular tachycardia electrocardiogram

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Catecholaminergic polymorphic ventricular tachycardia electrocardiogram

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There are no ECG findings associated with [disease name].

OR

An ECG may be helpful in the diagnosis of [disease name]. Findings on an ECG suggestive of/diagnostic of [disease name] include [finding 1], [finding 2], and [finding 3].

Electrocardiogram

References

  1. 1.0 1.1 Leenhardt, Antoine; Lucet, Vincent; Denjoy, Isabelle; Grau, Francis; Ngoc, Dien Do; Coumel, Philippe (1995). "Catecholaminergic Polymorphic Ventricular Tachycardia in Children". Circulation. 91 (5): 1512–1519. doi:10.1161/01.CIR.91.5.1512. ISSN 0009-7322.
  2. Hayashi, Meiso; Denjoy, Isabelle; Extramiana, Fabrice; Maltret, Alice; Buisson, Nathalie Roux; Lupoglazoff, Jean-Marc; Klug, Didier; Hayashi, Miyuki; Takatsuki, Seiji; Villain, Elisabeth; Kamblock, Joël; Messali, Anne; Guicheney, Pascale; Lunardi, Joël; Leenhardt, Antoine (2009). "Incidence and Risk Factors of Arrhythmic Events in Catecholaminergic Polymorphic Ventricular Tachycardia". Circulation. 119 (18): 2426–2434. doi:10.1161/CIRCULATIONAHA.108.829267. ISSN 0009-7322.
  3. Sumitomo, N (2003). "Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death". Heart. 89 (1): 66–70. doi:10.1136/heart.89.1.66. ISSN 0007-0769.
  4. Postma, A V (2005). "Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients". Journal of Medical Genetics. 42 (11): 863–870. doi:10.1136/jmg.2004.028993. ISSN 1468-6244.
  5. Neco, Patricia; Torrente, Angelo G.; Mesirca, Pietro; Zorio, Esther; Liu, Nian; Priori, Silvia G.; Napolitano, Carlo; Richard, Sylvain; Benitah, Jean-Pierre; Mangoni, Matteo E.; Gómez, Ana María (2012). "Paradoxical Effect of Increased Diastolic Ca 2+ Release and Decreased Sinoatrial Node Activity in a Mouse Model of Catecholaminergic Polymorphic Ventricular Tachycardia". Circulation. 126 (4): 392–401. doi:10.1161/CIRCULATIONAHA.111.075382. ISSN 0009-7322. line feed character in |title= at position 45 (help)
  6. Aizawa, Yoshiyasu; Komura, Satoru; Okada, Shinsuke; Chinushi, Masaomi; Aizawa, Yoshifusa; Morita, Hiroshi; Ohe, Tohru (2006). "Distinct U Wave Changes in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)". International Heart Journal. 47 (3): 381–389. doi:10.1536/ihj.47.381. ISSN 1349-2365.
  7. Sumitomo, Naokata; Sakurada, Harumizu; Taniguchi, Kazuo; Matsumura, Masaharu; Abe, Osamu; Miyashita, Michio; Kanamaru, Hiroshi; Karasawa, Kensuke; Ayusawa, Mamoru; Fukamizu, Seiji; Nagaoka, Iori; Horie, Minoru; Harada, Kensuke; Hiraoka, Masayasu (2007). "Association of Atrial Arrhythmia and Sinus Node Dysfunction in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia". Circulation Journal. 71 (10): 1606–1609. doi:10.1253/circj.71.1606. ISSN 1346-9843.
  8. Lawrenz, Wolfgang; Krogmann, Otto N.; Wieczorek, Marcus (2013). "Complex atrial arrhythmias as first manifestation of catecholaminergic polymorphic ventricular tachycardia: an unusual course in a patient with a new mutation in ryanodine receptor type 2 gene". Cardiology in the Young. 24 (4): 741–744. doi:10.1017/S1047951113001091. ISSN 1047-9511.
  9. van der Werf, Christian; Nederend, Ineke; Hofman, Nynke; van Geloven, Nan; Ebink, Corné; Frohn-Mulder, Ingrid M.E.; Alings, A. Marco W.; Bosker, Hans A.; Bracke, Frank A.; van den Heuvel, Freek; Waalewijn, Reinier A.; Bikker, Hennie; van Tintelen, J. Peter; Bhuiyan, Zahurul A.; van den Berg, Maarten P.; Wilde, Arthur A.M. (2012). "Familial Evaluation in Catecholaminergic Polymorphic Ventricular Tachycardia". Circulation: Arrhythmia and Electrophysiology. 5 (4): 748–756. doi:10.1161/CIRCEP.112.970517. ISSN 1941-3149.
  10. Sy, Raymond W.; Gollob, Michael H.; Klein, George J.; Yee, Raymond; Skanes, Allan C.; Gula, Lorne J.; Leong-Sit, Peter; Gow, Robert M.; Green, Martin S.; Birnie, David H.; Krahn, Andrew D. (2011). "Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia". Heart Rhythm. 8 (6): 864–871. doi:10.1016/j.hrthm.2011.01.048. ISSN 1547-5271.
  11. Sumitomo, Naokata; Nakamura, Takahiro; Fukuhara, Junji; Nakai, Toshiko; Watanabe, Ichiro; Mugishima, Hideo; Hiraoka, Masayasu (2010). "Clinical effectiveness of pulmonary vein isolation for arrhythmic events in a patient with catecholaminergic polymorphic ventricular tachycardia". Heart and Vessels. 25 (5): 448–452. doi:10.1007/s00380-009-1214-6. ISSN 0910-8327.
  12. Faggioni, Michela; van der Werf, Christian; Knollmann, Bjorn C. (2014). "Sinus node dysfunction in catecholaminergic polymorphic ventricular tachycardia: Risk factor and potential therapeutic target?". Trends in Cardiovascular Medicine. 24 (7): 273–278. doi:10.1016/j.tcm.2014.07.001. ISSN 1050-1738.

Template:WH Template:WS